Broncho-Vaxom is under clinical development by OM Pharma and currently in Phase I for Allergic Asthma. According to GlobalData, Phase I drugs for Allergic Asthma have a 78% phase transition success ...
First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...
Both babies were suffering from broncho-pneumonia. One of them has been discharged while the other is recovering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback